TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company’s shares closed today at $6.74. According to TipRanks, Brennan is a
TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company’s shares closed today at $6.74. According to TipRanks, Brennan is a
Sera Prognostics, Inc. (SERA) has disclosed a new risk, in the Technology category. Sera Prognostics, Inc. faces a significant business risk due to its reliance on both internal and external
Sera Prognostics, Inc. ( ($SERA) ) has released its Q3 earnings. Here is a breakdown of the information Sera Prognostics, Inc. presented to its investors. Sera Prognostics, Inc. is a
TD Cowen analyst Daniel Brennan maintained a Buy rating on Sera Prognostics (SERA – Research Report) today. The company’s shares closed yesterday at $7.40. Brennan covers the Healthcare sector, focusing
The company may offer and sell up to $100M of securities from time to time in one or more offerings. Published first on TheFly – the ultimate source for real-time,